Download Agenda

Sessions

10:30 - 11:45	Digital Technologies	Hall 6a
10:30 - 11:45	EP Masterclass 1	Hall 11a
10:30 - 11:45	Arrhythmogenic Cardiomyopathy: Updates and Best Practice	Executive Room 1
10:30 - 12:00	Oral Abstracts 1-Allied and Service Development	Hall 11b
11:30 - 18:45	EP Traces Course	Hall 7b
12:15 - 13:30	Masterclass Devices 1 -Tricuspid regurgitation and CIEDs – Optimal management strategies	Hall 11a
12:15 - 13:30	Oral Abstracts 1-Arrhythmia Clinical	Hall 11b
14:45 - 16:15	Conduction System Pacing 1	Hall 6a
14:45 - 16:15	AF Association Symposia 1	Hall 6b
14:45 - 16:00	Rhythm control should be considered first line in all patients with AF?	Hall 11a
14:45 - 16:15	Arrhythmia Alliance Symposia 1 - Focus on Conduction System Pacing	Hall 11b
14:45 - 16:15	Basic Science Primer	Executive Room 1
16:45 - 18:15	Year in Review 1 - AF what's new in 2024?	Hall 6a
16:45 - 18:15	AF Association Symposia 2 - Catheter Ablation in 2024: State of the Art	Hall 11a

Digital Technologies - Hall 6a - 10:30 - 11:45

	Chair: Dr Fu-Siong Ng, Dr Mark Tanner		London, UK, Chichester, UK
10:30	Direct to Consumer Wearables: Can we trust the data?	Dr Ahran Arnold	London, UK
10:45	Insights and Highlights from the `EHRA Digital Devices Practical Guide	Dr Katarzyna Malaczynska-Rajpold	London, UK
11:00	AI in a Nutshell: Current Applications in Arrhythmia Management	Prof Sanjiv Narayan	Palo Alto, US
11:15	Future Horizons in AI; Prognostic, Therapeutic, and Superhuman Diagnostics	Dr Arunashis Sau	London, UK
11:30	Final discussions
11:45	Close

EP Masterclass 1 - Hall 11a - 10:30 - 11:45

	Chair: Dr Manish Kalla, Dr Michala Pedersen		Birmingham, UK, Oxford, UK
10:30	Insights from PFA: is it more than park it by a vein and press ‘GO'	Dr Richard Balasubramaniam	Bournemouth, UK
10:45	When is moderate mitral regurgitation a reason to not offer AF ablation?	Dr Manav Sohal	London, UK
11:00	Is there space in the real world for ‘personalised ablation’ in persistent AF?	Dr Matt Wright	London, UK
11:15	Ablation for all severe heart failure patients with AF after CASTLE-HTX?	Dr David Jones	Uxbridge, UK
11:30	General anaesthesia or conscious sedation for PFA - is the jury still out?	Prof Nico Reinsch	Essen, DE
11:45	Close

Arrhythmogenic Cardiomyopathy: Updates and Best Practice - Executive Room 1 - 10:30 - 11:45

	Chair: Dr John Whitaker, Dr Stephen Page		London, UK, Leeds, UK
10:30	Arrhythmogenic cardiomyopathy - definitions and diagnostic criteria	Prof Juan Pablo Kaski	London, UK
10:45	The genetics of arrhythmogenic cardiomyopathy	Dr Verity Hartill	Leeds, UK
11:00	Assessing and managing risk in arrhythmogenic cardiomyopathy	Dr Oliver Watson	Sheffield, UK
11:15	How to perform catheter ablation in patients with arrhythmogenic cardiomyopathy	Dr John Silberbauer	Brighton, UK
11:30	Panel discussion
11:45	Close

Oral Abstracts 1-Allied and Service Development - Hall 11b - 10:30 - 12:00

	Chair: Dr Honey Thomas, Mr Stuart Allen		Northumberland, UK, Manchester, UK
10:30	IMPLANTABLE CARDIOVERTER DEFIBRILLATION IN PAEDIATRIC PATIENTS_ GREAT ORMOND STREET HOSPITAL EXPERIENCE	Naif Alqweai	London, UK
10:45	A PHYSIOLOGIST-LED SERVICE MANAGING CHANNELOPATHY PATIENTS WITH CARDIAC IMPLANTABLE ELECTRONIC DEVICES	Lucy Moore	Manchester, UK
11:00	SINGLE CENTRE EXPERIENCE OF EXTRAVASCULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS: FROM PIVOTAL TO COMMERCIAL	Parisha Khan	London, UK
11:15	SNAPSHOT REVIEW OF BIVENTRICULAR PACING BURDENS ACROSS OUR TRUST. HOW MANY OF OUR PATIENTS RECEIVE A ≥98% CARDIAC RESYNCHRONISATION THERAPY?	Adam Simpson	Manchester, UK
11:30	EVALUATING MODERN CARDIAC RESYNCHRONISATION THERAPY; WHAT ARE THE RESPONSE RATES AND HOW DO THEY COMPARE TO THE RANDOMISED CONTROLLED TRIALS?	Emma Burton	Middlesbrough, UK
11:45	INVESTIGATING NHS SERVICE PROVISION FOR PATIENTS WITH POSTURAL TACHYCARDIA SYNDROME IN THE UK WITH A VIEW TO IMPROVING UNDERSTANDING ACCESS AND OUTCOMES FOR PATIENTS	Philippa Turner	Birmingham, UK
12:00	Close

EP Traces Course - Hall 7b - 11:30 - 18:45

	Thank you to our sponsors, Medtronic and Boston Scientific
	Chair: Dr Adam Graham, Dr Dewi Thomas, Dr Simon Modi		Nottingham, UK, Swansea, UK, Liverpool, UK
11:30	Welcome, course objectives and ‘How to approach the unknown tracing’
11:45	EP traces session 1 - 4 (please note there will be lunch, followed by 2 x breaks throughout the day)
18:45	Close

Masterclass Devices 1 -Tricuspid regurgitation and CIEDs – Optimal management strategies - Hall 11a - 12:15 - 13:30

	Chair: Dr Archie Rao, Dr Peysh Patel		Liverpool, UK, Birmingham, UK
12:15	Size of problem/predictors of the problem - Overview – how often is it a reality	Dr Colin Cunnington	Manchester, UK
12:40	Multimodality imaging and Assessment of TR	Dr James Dundas	Stockton-on-Tees, UK
13:05	Management of TR in the device patient	Dr Chris Pepper	Leeds, UK
13:30	Close

Oral Abstracts 1-Arrhythmia Clinical - Hall 11b - 12:15 - 13:30

	Chair: Dr Mokhtar Ibrahim, Dr William Foster		Leicester, UK, Worcester, UK
12:15	ATRIAL FIBRILLATION VIRTUAL WARD: EFFECTIVE ARRHYTHMIA CARE BUT LIMITED DEMAND	Josephine Mansell	London, UK
12:30	USE OF AN AMBULATORY ECG PATCH AS AN ALTERNATIVE TO TRADITIONAL HOLTER MONITORING IN THE INITIAL INVESTIGATION OF ARRHYTHMIA - A DGH EXPERIENCE	Reny Mathai	Chichester, UK
12:45	PULSED FIELD ABLATION FOR THE TREATMENT OF ATRIAL FIBRILLATION IN PATIENTS WITH HEART FAILURE - OUTCOMES AND BENEFITS COMPARED TO RADIOFREQUENCY ABLATION	Omar Ahmed	London, UK
13:00	REAL WORLD OUTCOMES FOR ATRIAL FIBRILLATION ABLATION IN PATIENTS WITH BMI OVER 30 - ARE NHS ENGLAND COMMISSIONING GUIDELINES APPROPRIATE?	Thomas Slater	Leeds, UK
13:15	THE EFFECTIVENESS OF THORACOSCOPIC TREATMENT OF PERSISTENT AND LONG-TERM PERSISTENT FORMS OF ATRIAL FIBRILLATION DURING A THREE-YEAR FOLLOW-UP PERIOD	Elizaveta Strebkova	Moscow, RU
13:30	Close

Conduction System Pacing 1 - Hall 6a - 14:45 - 16:15

	Chair: Dr Antony French, Dr Jenny Chuen		Hereford, UK, Nottingham, UK
	Will CSP replace conventional CRT?
14:45	Pro	Dr Mokhtar Ibrahim	Leicester, UK
15:05	Con	Prof Francisco Leyva	Birmingham, UK
	Will CSP replace conventional RV pacing?
15:25	Pro	Dr Badrinathan Chandrasekaran	Swindon, UK
15:45	Con	Dr Ian Loke	Leicester, UK
16:05	Q&A
16:15	Close

AF Association Symposia 1 - Hall 6b - 14:45 - 16:15

	Chair: Prof Pier Lambiase, Dr Rosita Zakeri		London, UK, London, UK
14:45	Comparing pulsed field electroporation and radiofrequency ablation for the treatment of paroxysmal atrial fibrillation: Design and rationale of the BEAT PAROX-AF randomized clinical trial	Dr Nico Erhard	Munich, DE
15:00	HFrEF - AF ablation or not?	Prof Mark Petrie	Glasgow, UK
15:15	HFpEF - AF ablation or not?	Dr Rosita Zakeri	London, UK
15:30	AF ablation in HF - does the "how" matter?	Prof Pier Lambiase	London, UK
15:45	Q&A
16:15	Close

Rhythm control should be considered first line in all patients with AF? - Hall 11a - 14:45 - 16:00

	Chair: Dr Angela Griffiths		Oxford, UK
14:45	Pro	Prof Derek Connelly	Glasgow, UK
15:15	Con	Dr Christian Camm	Reading, UK
15:45	Final discussions
16:00	Close

Arrhythmia Alliance Symposia 1 - Focus on Conduction System Pacing - Hall 11b - 14:45 - 16:15

	Chair: Dr Karol Curila, Prof Zachary Whinnett		Prague, CZ, London, UK
14:45	Performing LBBAP in a DGH setting	Dr Jagdeep Singh	Edinburgh, UK
15:00	When should I consider CSP for CRT and what approach should I use?	Dr Nadine Ali	London, UK
15:15	Delivering CSP in clinical practice: overview of guidelines and consensus documents	Dr Mark Tanner	Chichester, UK
15:30	Does it matter which part of the conduction system we capture?	Dr Karol Curila	Prague, CZ
15:45	How to confirm conduction system capture: insights from invasive mapping studies	Dr Ahran Arnold	London, UK
16:00	Panel discussion
16:15	Close

Basic Science Primer - Executive Room 1 - 14:45 - 16:15

	Chair: Dr Fu-Siong Ng, Dr Rachel Myles		London, UK, Glasgow, UK
14:45	Conduction system dysfunction in athletes	Dr Alicia D'Souza	London, UK
15:05	In silico trials for drug development	Dr Albert Dasi	Oxford, UK
15:25	AI-enabled electrocardiogram for risk prediction	Dr Fu-Siong Ng	London, UK
15:45	Ventricular arrhythmia mechanisms in LQTS	Dr Rachel Myles	Glasgow, UK
16:05	Final discussions
16:15	Close

Year in Review 1 - AF what's new in 2024? - Hall 6a - 16:45 - 18:15

	Chair: Prof Derek Connolly, Dr Honey Thomas		Birmingham, UK, Northumberland, UK
16:45	Anticoagulation - Current and future developments / top 10 messages from ESC guidelines	Dr Matthew Dewhurst	Stockton on Tees, UK
17:10	Percutaneous / surgical approaches to stroke reduction
17:35	Ablation techniques - QDOT/PFA - Safety/efficacy - Anything other than the veins? 1 size fits all vs personalized approach for all	Dr Andy Thornley	Middlesbrough, UK
18:00	Pulse select	Mr Mike Berry	London, UK
18:10	Final discussions
18:15	Close

AF Association Symposia 2 - Catheter Ablation in 2024: State of the Art - Hall 11a - 16:45 - 18:15

	Chair: Dr Shouvik Haldar, Prof Tom Wong		London, UK, London, UK
16:45	Catheter ablation of AF Then and Now: A Historical Perspective	Dr Nico Erhard	Munich, DE
16:55	Techniques and Outcomes of Thermal AF Ablation in 2024	Dr David Jones	Uxbridge, UK
17:05	Persistent atrial fibrillation ablation: from endocardial to epicardial	Dr John Silberbauer	Brighton, UK
17:15	Electroporation: A State-of-the-Art Review	Prof Tom Wong	London, UK
17:25	First Line AF Ablation	Dr Merzaka Lazdam	Leicester, UK
17:35	AF Ablation: Predictions for the future	Dr Matt Wright	London, UK
17:45	The Future of AF Ablation in the NHS	Dr Muzahir Tayebjee	Leeds, UK
18:15	Close